期刊文献+

血清胱抑素C对肾脏病诊断的价值

The Value of Serum Cystatin C in the Diagnosis of Renal Diseases
下载PDF
导出
摘要 血清胱抑素C (CysC)是一种细胞外抑制素,在体液中丰富的表达,可能对间质半胱氨酸蛋白酶有抑制作用。分子量较小,产生率恒定,可以调控细胞内外的蛋白水解,并且可经肾小球过滤,在近曲小管重吸收和代谢,肾脏是将其清除的唯一器官,同时,它不受性别、年龄、饮食等因素影响。血清胱抑素C (CysC)测定是测定肾脏病患者肾功能的一种简单实用的方法。最近的研究表明,CysC在预测肾损害的早期阶段具有更好的诊断准确性或至少相当于肌酐,并且与透析患者的临床结果密切相关。因此,胱抑素C在肾脏疾病、肿瘤、糖尿病、肝硬化、心脏病的诊断中有一定价值,本文对血清胱抑素C在肾脏病诊断中的价值作一论述。 Serum cystatin C (CysC) is a kind of extracellular inhibin, which is abundant in body fluid and may inhibit interstitial cysteine protease. The molecular weight is small, the production rate is constant, it can regulate the protein hydrolysis inside and outside the cell, and it can be filtered by the glomerulus and reabsorbed and metabolized in the proximal convoluted tubule. The kidney is the only organ to remove it, and at the same time, it is not affected by sex, age, diet and other factors. The determination of serum cystatin C (CysC) is a simple and practical method to measure the renal function of patients with renal disease. Recent studies have shown that CysC is more accurate or at least equivalent to creatinine in predicting the early stage of renal damage and is closely related to the clinical outcome of dialysis patients. Therefore, cystatin C has certain value in the diagnosis of kidney disease, tumor, diabetes, liver cirrhosis and heart disease. This paper discusses the value of serum cystatin C in the diagnosis of kidney disease.
出处 《临床医学进展》 2020年第8期1689-1693,共5页 Advances in Clinical Medicine
关键词 血清胱抑素C 肾功能损害 肾脏病诊断 Serum Cystatin C Renal Damage Diagnosis of Kidney Disease
  • 相关文献

参考文献7

二级参考文献77

  • 1Tian, Xin-Ping,Zhang, Xuan.Gastrointestinal involvement in systemic lupus erythematosus:Insight into pathogenesis, diagnosis and treatment[J].World Journal of Gastroenterology,2010,16(24):2971-2977. 被引量:55
  • 2彭炎强,史伟,叶智明,梁馨苓,何朝生,章斌,王文健,梁永正.检测血清胱抑素C诊断急性肾衰竭的研究[J].新医学,2005,36(10):570-572. 被引量:23
  • 3Cepeda FJ, Fernandez E, Pobes A, et al. Utility of cystatin -C in hospitalized patients. Comparing with different methods of assessing renal function[J] Nefrologia, 2007, 27 ( 2 ) : 168-174.
  • 4Yang YS,Peng CH,Liu CK,et al. Use of serum cystatin C to detect early decline of glomerular filtration rate in type2 diabetes[J]. J Intern Med J,2007,46(12): 801- 806.
  • 5Jiborn T, Ahrahamson M, WalIn H, et al. Cystatin C is highly expressed in the human male reproductive system[J]. J Androl, 2004,25 (4): 564-572.
  • 6Coil E,Botey A,Alvarez L,et al. Serum eystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [J]. Am J Kidney Dis,2000,36(1) :29-34.
  • 7Aksun SA, Ozmen D, Ozmen B, et al. Beta2 microglobulin and eystatin C in type2 diabetes: assessment of diabetic nephropathy[J]. Exp Clin Endoerinol Diabetes, 2004, 112 (4) : 195-200.
  • 8Uslu S, Efe B, Alatas O, et al. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients[J]. J Nephrol, 2005,18 (5): 559-567.
  • 9Mangge H, Iebmann P, Tanil H, et al. Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis [J]. Clin Chim ACTA,2000,300 (1-2): 195-202.
  • 10Conti M,Moutereau S,Zater M,et al. Urinary cystatin C as a specific marker of tubular dysfunction[J]. Clin Chem Lab Med,2006,44 (3) :288-291.

共引文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部